108 related articles for article (PubMed ID: 38741435)
1. Safety of GMP-compliant iPSC lines generated by Sendai virus transduction is dependent upon clone identity and sex of the donor.
Kuczynska Z; Neglur PK; Metin E; Liput M; Zychowicz M; Zayat V; Krześniak NE; Buzanska L; Kot M
Folia Neuropathol; 2024; 62(1):32-46. PubMed ID: 38741435
[TBL] [Abstract][Full Text] [Related]
2. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
[TBL] [Abstract][Full Text] [Related]
3. Generation of induced pluripotent stem cell line NIMHi010-A from dermal fibroblast cells of a healthy individual.
Dash SS; Arunachal G; Nimonkar MM; Vengalil S; Nashi S; Chetan GK; Boddu VK; Nalini A; Markandeya YS
Stem Cell Res; 2024 Apr; 76():103355. PubMed ID: 38412659
[TBL] [Abstract][Full Text] [Related]
4. Generation of induced pluripotent stem cell line (VRISGi004-A) from a healthy female donor by reprogramming erythroid progenitor cells.
Luong TH; Pham TA; Nhung Nguyen TH; Nguyen XH
Stem Cell Res; 2024 Apr; 76():103331. PubMed ID: 38341988
[TBL] [Abstract][Full Text] [Related]
5. Xeno-Free Reprogramming of Peripheral Blood Mononuclear Erythroblasts on Laminin-521.
Skorik C; Mullin NK; Shi M; Zhang Y; Hunter P; Tang Y; Hilton B; Schlaeger TM
Curr Protoc Stem Cell Biol; 2020 Mar; 52(1):e103. PubMed ID: 31977148
[TBL] [Abstract][Full Text] [Related]
6. Generation of an erythroid progenitor-derived iPSC line, VRISGi002-A, from a healthy 27-year-old Vietnamese donor under a feeder-free system.
Nhung Nguyen TH; Trinh Tran TT; Luong TH; Nguyen XH
Stem Cell Res; 2022 Jul; 62():102824. PubMed ID: 35679757
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of targeted differentiation of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells reveals variability associated with incomplete transgene silencing in retrovirally derived hiPSC lines.
Toivonen S; Ojala M; Hyysalo A; Ilmarinen T; Rajala K; Pekkanen-Mattila M; Äänismaa R; Lundin K; Palgi J; Weltner J; Trokovic R; Silvennoinen O; Skottman H; Narkilahti S; Aalto-Setälä K; Otonkoski T
Stem Cells Transl Med; 2013 Feb; 2(2):83-93. PubMed ID: 23341440
[TBL] [Abstract][Full Text] [Related]
8. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
[TBL] [Abstract][Full Text] [Related]
9. A Protocol for Culture and Characterization of Human Induced Pluripotent Stem Cells After Induction.
Cheng YS; Xu M; Chen G; Beers J; Chen CZ; Liu C; Zou J; Zheng W
Curr Protoc; 2023 Aug; 3(8):e866. PubMed ID: 37610273
[TBL] [Abstract][Full Text] [Related]
10. Generation of two lymphoblastoid-derived induced pluripotent stem cell (iPSC) lines from patients with phenylketonuria.
Veleva D; Ay M; Ovchinnikov DA; Prowse ABJ; Menezes MJ; Nafisinia M
Stem Cell Res; 2024 Jun; 77():103407. PubMed ID: 38552357
[TBL] [Abstract][Full Text] [Related]
11. Reprogramming human dermal fibroblast into induced pluripotent stem cells using nonintegrative Sendai virus for transduction.
Tai L; Teoh HK; Cheong SK
Malays J Pathol; 2018 Dec; 40(3):325-329. PubMed ID: 30580364
[TBL] [Abstract][Full Text] [Related]
12. Increased reprogramming of human fetal hepatocytes compared with adult hepatocytes in feeder-free conditions.
Hansel MC; Gramignoli R; Blake W; Davila J; Skvorak K; Dorko K; Tahan V; Lee BR; Tafaleng E; Guzman-Lepe J; Soto-Gutierrez A; Fox IJ; Strom SC
Cell Transplant; 2014 Jan; 23(1):27-38. PubMed ID: 23394081
[TBL] [Abstract][Full Text] [Related]
13. Good Manufacturing Practice-compliant human induced pluripotent stem cells: from bench to putative clinical products.
Novoa JJ; Westra IM; Steeneveld E; Fonseca Neves N; Arendzen CH; Rajaei B; Grundeken E; Yildiz M; van der Valk W; Salvador A; Carlotti F; Dijkers PF; Locher H; van den Berg CW; Raymond KI; Kirkeby A; Mummery CL; Rabelink TJ; Freund C; Meij P; Wieles B
Cytotherapy; 2024 Jun; 26(6):556-566. PubMed ID: 38483359
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a Vietnamese ethnicity induced pluripotent stem cell line (VRISGi001-A) from umbilical cord blood hematopoietic stem cells under a feeder-free system.
Tran TT; Nguyen TH; Nguyen TT; Nguyen XH
Stem Cell Res; 2021 May; 53():102345. PubMed ID: 33878709
[TBL] [Abstract][Full Text] [Related]
15. Induction of pluripotent stem cells from autopsy donor-derived somatic cells.
Hjelm BE; Rosenberg JB; Szelinger S; Sue LI; Beach TG; Huentelman MJ; Craig DW
Neurosci Lett; 2011 Sep; 502(3):219-24. PubMed ID: 21839145
[TBL] [Abstract][Full Text] [Related]
16. Generation of human induced pluripotent stem cell lines from human dermal fibroblasts using a non-integration system.
Uhm KO; Kim SJ; Jo EH; Go GY; Choi HY; Im YS; Ha HY; Kim JH; Koo SK
Stem Cell Res; 2017 May; 21():13-15. PubMed ID: 28677527
[TBL] [Abstract][Full Text] [Related]
17. Generation of induced pluripotent stem cell line (RCMGi009-A) from urine cells of patient with fibrodysplasia ossificans progressiva.
Kondrateva E; Grigorieva O; Kurshakova E; Panchuk I; Pozhitnova V; Voronina E; Tabakov V; Orlova M; Lavrov A; Smirnikhina S; Kutsev S
Stem Cell Res; 2023 Aug; 70():103133. PubMed ID: 37307755
[TBL] [Abstract][Full Text] [Related]
18. Generation of three human iPSC lines from a retinitis pigmentosa family with SLC7A14 mutation.
Li YP; Liu H; Jin ZB
Stem Cell Res; 2020 Dec; 49():102075. PubMed ID: 33207307
[TBL] [Abstract][Full Text] [Related]
19. Reprogramming of a human induced pluripotent stem cell line from one 48-year-old healthy male donor.
Guo R; Mu W; Liu X; Zhang J; Liu B; Du X; He J; Ma J; Cui H
Stem Cell Res; 2021 May; 53():102339. PubMed ID: 33892291
[TBL] [Abstract][Full Text] [Related]
20. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.
Ramos-Mejía V; Montes R; Bueno C; Ayllón V; Real PJ; Rodríguez R; Menendez P
PLoS One; 2012; 7(4):e35824. PubMed ID: 22545141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
